Janet McLaughlin is an Associate Professor of Health Studies and a Research Associate with the International Migration Research Centre at Wilfrid Laurier University. She is an interdisciplinary scholar trained in medical anthropology, with interests in the areas of global and environmental health, food systems, labour, social justice, citizenship, transnational migration and the social impacts of autism. Her research and publications have focused on various areas of migrant workers’ health, rights and well-being, including: access to health care and workers’ compensation; women’s experiences of gender-based violence; occupational, mental, sexual and reproductive health; social determinants of health; and the impacts of separation on migrant families. She is co-founder of the Migrant Worker Health Project, www.migrantworkerhealth.ca, which promotes accessible health care for migrant workers. Dr. McLaughlin is currently researching autism policy and family impacts in Ontario.
Janet McLaughlin
From this contributor
Changes to Canada autism program could do more harm than good
The Ontario, Canada, government recently announced its intentions to overhaul the Ontario Autism Program, but the changes could leave autistic children without supports.
Changes to Canada autism program could do more harm than good
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.